Is CPHI or DERM more undervalued in 2026?

CirclFi compares China Pharma Holdings, Inc. (CPHI) and Journey Medical Corporation (DERM) using 13 institutional-grade valuation models. CPHI has a Quality of Company score of 3.9/10 while DERM scores 5.7/10.

Which is a better buy — CPHI or DERM?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CPHI and DERM valuations compare?

CPHI at $0.76 and DERM at $6.20 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CPHI vs DERM Valuation Comparison 2026 — Intrinsic Value Analysis

CPHI

Drug Manufacturers - Specialty & Generic

China Pharma Holdings, Inc.

Quality

3.9

out of 10

Value Trap

WARN

Price

$0.76

Last close

Models

10/13

Active

DERM

Drug Manufacturers - Specialty & Generic

Journey Medical Corporation

Quality

5.7

out of 10

Value Trap

SAFE

Price

$6.20

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	CPHI Fair Value	CPHI Upside	DERM Fair Value	DERM Upside
Bayesian DCF	Intrinsic	$0.27	-59.4%	$1.27	-79.4%
Earnings Power Value	Intrinsic	—	—	$1.89	-63.5%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.06	-91.7%	$0.12	-97.7%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CPHI vs DERM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CPHI vs DERM — Which Stock Is More Undervalued?

DERM scores higher with a 5.7/10 quality rating vs CPHI's 3.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing China Pharma Holdings, Inc. (CPHI) and Journey Medical Corporation (DERM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CPHI currently trades at $0.76 with a QOC of 3.9/10, while DERM trades at $6.20 with a QOC of 5.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).